These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 28994624)

  • 1. Plasma heparanase is associated with blood glucose levels but not urinary microalbumin excretion in type 2 diabetic nephropathy at the early stage.
    Zhao Y; Liu J; Ten S; Zhang J; Yuan Y; Yu J; An X
    Ren Fail; 2017 Nov; 39(1):698-701. PubMed ID: 28994624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma sRAGE is not associated with urinary microalbumin excretion in type 2 diabetic nephropathy at the early stage.
    Yu JY; An XF; Liu JS; Ten SC; Wang X; Zhao Y; Huang S; Gu WJ; Gao F
    Diabetes Res Clin Pract; 2010 Feb; 87(2):157-60. PubMed ID: 19945761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus.
    Kim NH; Kim KB; Kim DL; Kim SG; Choi KM; Baik SH; Choi DS; Kang YS; Han SY; Han KH; Ji YH; Cha DR
    Diabet Med; 2004 Jun; 21(6):545-51. PubMed ID: 15154937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of plasma growth differentiation factor-15 in diagnosis and evaluation of type 2 diabetic nephropathy].
    Li H; Gao F; Xue Y; Qian Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Mar; 34(3):387-90. PubMed ID: 24670455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum osteoprotegerin and tumor necrosis factor related apoptosis inducing-ligand (TRAIL) are elevated in type 2 diabetic patients with albuminuria and serum osteoprotegerin is independently associated with the severity of diabetic nephropathy.
    Chang YH; Lin KD; He SR; Hsieh MC; Hsiao JY; Shin SJ
    Metabolism; 2011 Aug; 60(8):1064-9. PubMed ID: 21251686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocan and albuminuria in type 2 diabetes mellitus.
    Cikrikcioglu MA; Erturk Z; Kilic E; Celik K; Ekinci I; Yasin Cetin AI; Ozkan T; Cetin G; Dae SA; Kazancioglu R; Erkoc R
    Ren Fail; 2016 Nov; 38(10):1647-1653. PubMed ID: 27756187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tocotrienol-Rich Vitamin E from Palm Oil (Tocovid) and Its Effects in Diabetes and Diabetic Nephropathy: A Pilot Phase II Clinical Trial.
    Tan SMQ; Chiew Y; Ahmad B; Kadir KA
    Nutrients; 2018 Sep; 10(9):. PubMed ID: 30227659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical implication of plasma and urine YKL-40, as a proinflammatory biomarker, on early stage of nephropathy in type 2 diabetic patients.
    Lee JH; Kim SS; Kim IJ; Song SH; Kim YK; In Kim J; Jeon YK; Kim BH; Kwak IS
    J Diabetes Complications; 2012; 26(4):308-12. PubMed ID: 22705282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy.
    Li Z; Xu Y; Liu X; Nie Y; Zhao Z
    Nephrology (Carlton); 2017 Jan; 22(1):58-64. PubMed ID: 26733347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SH3YL1 protein as a novel biomarker for diabetic nephropathy in type 2 diabetes mellitus.
    Choi GS; Min HS; Cha JJ; Lee JE; Ghee JY; Yoo JA; Kim KT; Kang YS; Han SY; Bae YS; Lee SR; Yoo JY; Moon SH; Lee SJ; Cha DR
    Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):498-505. PubMed ID: 33223406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary heparanase activity in patients with Type 1 and Type 2 diabetes.
    Rops AL; van den Hoven MJ; Veldman BA; Salemink S; Vervoort G; Elving LD; Aten J; Wetzels JF; van der Vlag J; Berden JH
    Nephrol Dial Transplant; 2012 Jul; 27(7):2853-61. PubMed ID: 22187315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble α-klotho as a novel biomarker in the early stage of nephropathy in patients with type 2 diabetes.
    Lee EY; Kim SS; Lee JS; Kim IJ; Song SH; Cha SK; Park KS; Kang JS; Chung CH
    PLoS One; 2014; 9(8):e102984. PubMed ID: 25084095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased plasma α-Klotho predict progression of nephropathy with type 2 diabetic patients.
    Kim SS; Song SH; Kim IJ; Lee EY; Lee SM; Chung CH; Kwak IS; Lee EK; Kim YK
    J Diabetes Complications; 2016 Jul; 30(5):887-92. PubMed ID: 27037042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The changes of serum sKlotho and NGAL levels and their correlation in type 2 diabetes mellitus patients with different stages of urinary albumin.
    Wu C; Wang Q; Lv C; Qin N; Lei S; Yuan Q; Wang G
    Diabetes Res Clin Pract; 2014 Nov; 106(2):343-50. PubMed ID: 25263500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum klotho protein levels and their correlations with the progression of type 2 diabetes mellitus.
    Nie F; Wu D; Du H; Yang X; Yang M; Pang X; Xu Y
    J Diabetes Complications; 2017 Mar; 31(3):594-598. PubMed ID: 27916483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycated peptides are associated with the variability of endothelial dysfunction in the cerebral vessels and the kidney in type 2 diabetes mellitus patients: a cross-sectional study.
    Petrica L; Vlad A; Gluhovschi G; Gadalean F; Dumitrascu V; Vlad D; Popescu R; Velciov S; Gluhovschi C; Bob F; Ursoniu S; Petrica M; Jianu DC
    J Diabetes Complications; 2015 Mar; 29(2):230-7. PubMed ID: 25511877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma glycooxidation protein products in type 2 diabetic patients with nephropathy.
    Piwowar A; Knapik-Kordecka M; Szczecińska J; Warwas M
    Diabetes Metab Res Rev; 2008 Oct; 24(7):549-53. PubMed ID: 18613218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function.
    Chen CC; Susanto H; Chuang WH; Liu TY; Wang CH
    Cardiovasc Diabetol; 2016 Jan; 15():3. PubMed ID: 26739836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension.
    Busch M; Franke S; Wolf G; Brandstädt A; Ott U; Gerth J; Hunsicker LG; Stein G;
    Am J Kidney Dis; 2006 Oct; 48(4):571-9. PubMed ID: 16997053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Angptl2 levels are independently associated with albuminuria in type 2 diabetes.
    Li Q; Gong W; Yang Z; Lu B; Yang Y; Zhao W; Hu R
    Diabetes Res Clin Pract; 2013 Jun; 100(3):385-90. PubMed ID: 23602322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.